Published in Eur J Immunol on June 01, 1999
In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma. Br J Cancer (2001) 0.96
Plasmid IL-12 electroporation in melanoma. Hum Vaccin Immunother (2012) 0.83
Functional role of type I and type II interferons in antiviral defense. Science (1994) 18.92
Immune response in mice that lack the interferon-gamma receptor. Science (1993) 12.15
Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med (1998) 7.48
Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J (1995) 6.94
Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med (1999) 6.04
Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature (2001) 3.99
Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J Virol (2001) 3.65
Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N Engl J Med (1999) 3.37
cDNA structures and regulation of two interferon-induced human Mx proteins. Mol Cell Biol (1989) 3.20
Measles virus spread and pathogenesis in genetically modified mice. J Virol (1998) 2.84
A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J (1998) 2.48
The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur J Immunol (1995) 2.47
Induction of the PML protein by interferons in normal and APL cells. Leukemia (1995) 2.05
Hypo- and hyperpigmented areas in incontinentia pigmenti. Light and electron microscopic studies. Am J Dermatopathol (1991) 1.93
Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells. Blood (2001) 1.74
Inhibition of vesicular stomatitis virus mRNA synthesis by human MxA protein. J Virol (1991) 1.74
Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol (1991) 1.68
Management of leg ulcers in patients with rheumatoid arthritis or systemic sclerosis: the importance of concomitant arterial and venous disease. J Vasc Surg (2000) 1.65
A functional GTP-binding motif is necessary for antiviral activity of Mx proteins. J Virol (1993) 1.64
Mechanism of human MxA protein action: variants with changed antiviral properties. EMBO J (1992) 1.63
Human MxA protein protects mice lacking a functional alpha/beta interferon system against La crosse virus and other lethal viral infections. J Virol (1999) 1.62
A subcutaneous delta-positive T-cell lymphoma that produces interferon gamma. N Engl J Med (1991) 1.59
Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon. J Virol (1994) 1.56
Clinicopathological spectrum of mycosis fungoides. J Eur Acad Dermatol Venereol (2004) 1.55
Eosinophilic myositis with eosinophilic cellulitislike skin lesions. Association with increased serum levels of eosinophil cationic protein and interleukin-5. Arch Dermatol (1997) 1.54
Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins. J Virol (1998) 1.53
A multicenter phase II clinical trial using dacarbazine and continuous infusion interleukin-2 for metastatic melanoma. Clinical data and immunomonitoring. Cancer (1995) 1.52
Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules. Int J Cancer (1997) 1.50
Accuracy, concordance, and reproducibility of histologic diagnosis in cutaneous T-cell lymphoma: an EORTC Cutaneous Lymphoma Project Group Study. European Organization for Research and Treatment of Cancer. Arch Dermatol (2000) 1.49
Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice. J Virol (2000) 1.48
Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients. J Clin Oncol (1998) 1.46
Basal cell carcinomas in a tertiary referral centre: a systematic analysis. Br J Dermatol (2014) 1.46
Mx proteins: GTPases with antiviral activity. Trends Cell Biol (1993) 1.45
MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line. J Virol (1993) 1.43
[Infected myxoma as a cause of acute infective endocarditis]. Vnitr Lek (2010) 1.42
PAX3 is expressed in human melanomas and contributes to tumor cell survival. Cancer Res (2001) 1.42
In melanoma, beta-catenin is a suppressor of invasion. Oncogene (2011) 1.40
Spitz nevi display allelic deletions. Arch Dermatol (2001) 1.40
Pityriasis rosea is not associated with human herpesvirus 7. Arch Dermatol (1999) 1.39
Irritant reactivity is a better risk marker for nickel sensitization than atopy. Acta Derm Venereol (1993) 1.39
Historic treasures in a new museum: dermatologic and surgical wax models. Int J Dermatol (1995) 1.38
The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures. Hum Gene Ther (1998) 1.36
Overexpression of the influenza virus polymerase can titrate out inhibition by the murine Mx1 protein. J Virol (1992) 1.36
Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am J Pathol (2001) 1.35
Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus. J Gen Virol (1995) 1.34
Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells. J Virol (1994) 1.34
Function of the mouse Mx1 protein is inhibited by overexpression of the PB2 protein of influenza virus. Virology (1993) 1.34
[Inflammatory infiltrate in psoriasis vulgaris. A cytochemical study]. Arch Klin Exp Dermatol (1970) 1.33
Roles of macrophages in measles virus infection of genetically modified mice. J Virol (2001) 1.33
Peripheral clonal deletion of antiviral memory CD8+ T cells. Eur J Immunol (1993) 1.28
Nuclear localization of mouse Mx1 protein is necessary for inhibition of influenza virus. J Virol (1992) 1.28
Serological detection of cutaneous T-cell lymphoma-associated antigens. Proc Natl Acad Sci U S A (2001) 1.24
Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. J Clin Oncol (1997) 1.20
Drug-induced lichen planus. Clin Dermatol (1998) 1.20
The causes of hospital-treated acute lower respiratory tract infection in children. Am J Dis Child (1991) 1.20
[The effect of dithranol in psoriasis fulgaris. Cyto- and histochemical investigations]. Arch Dermatol Forsch (1971) 1.20
[Histochemistry of capillaries in psoriasis vulgaris]. Arch Klin Exp Dermatol (1970) 1.19
Mouse Mx2 protein inhibits vesicular stomatitis virus but not influenza virus. Virology (1992) 1.17
Biomarkers in melanoma. Ann Oncol (2009) 1.17
First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07). Ann Oncol (2011) 1.16
Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics. J Control Release (1999) 1.16
Primary cutaneous melanoma. Prognostic classification of anatomic location. Cancer (1995) 1.15
Sézary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain). Blood (1996) 1.13
Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer (1995) 1.12
[Anaphylaxis following ingestion of coffee, chronic urticaria and analgesics idiosyncrasy]. Hautarzt (1983) 1.12
[Histochemical and cytochemical investigations in allergic DNCB-contact dermatitis of the guinea pig]. Arch Klin Exp Dermatol (1970) 1.11
Cutaneous lymphomas consist of a spectrum of nosologically different entities including mycosis fungoides and small plaque parapsoriasis. Arch Dermatol (1996) 1.09
Pseudo-melanoma after laser therapy. Dermatology (1998) 1.09
Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature. Br J Dermatol (2003) 1.09
Small molecules and targeted therapies in distant metastatic disease. Ann Oncol (2009) 1.08
Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions. Br J Dermatol (1997) 1.08
Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells. Blood (1998) 1.07
The optimal use of bexarotene in cutaneous T-cell lymphoma. Br J Dermatol (2007) 1.06
A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up. J Eur Acad Dermatol Venereol (2008) 1.06
Functional and selective targeting of adenovirus to high-affinity Fcgamma receptor I-positive cells by using a bispecific hybrid adapter. J Virol (2001) 1.05
Expression of MxA protein in inflammatory dermatoses. J Histochem Cytochem (1995) 1.05
The first three years of the Swiss Neuropaediatric Stroke Registry (SNPSR): a population-based study of incidence, symptoms and risk factors. Neuropediatrics (2005) 1.04
Dermatofibroma: an abortive immunoreactive process mediated by dermal dendritic cells? Dermatology (1995) 1.04
Superficial acral fibromyxoma: report of two cases. Dermatology (2002) 1.03